206 related articles for article (PubMed ID: 32898245)
1. AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma.
Bloedjes TA; de Wilde G; Maas C; Eldering E; Bende RJ; van Noesel CJM; Pals ST; Spaargaren M; Guikema JEJ
Blood Adv; 2020 Sep; 4(17):4151-4164. PubMed ID: 32898245
[TBL] [Abstract][Full Text] [Related]
2. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
Huo X; Liu S; Shao T; Hua H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2014 Sep; 289(36):24759-70. PubMed ID: 25053419
[TBL] [Abstract][Full Text] [Related]
3. The E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signaling.
Terragni J; Nayak G; Banerjee S; Medrano JL; Graham JR; Brennan JF; Sepulveda S; Cooper GM
J Biol Chem; 2011 Oct; 286(42):36215-27. PubMed ID: 21873430
[TBL] [Abstract][Full Text] [Related]
4. p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling.
Nayak G; Cooper GM
Cell Death Dis; 2012 Oct; 3(10):e400. PubMed ID: 23059819
[TBL] [Abstract][Full Text] [Related]
5. AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity.
Bloedjes TA; de Wilde G; Khan GH; Ashby TC; Shaughnessy JD; Zhan F; Houtkooper RH; Bende RJ; van Noesel CJM; Spaargaren M; Guikema JEJ
Blood Adv; 2023 May; 7(9):1697-1712. PubMed ID: 36322819
[TBL] [Abstract][Full Text] [Related]
6. Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
G-Amlak M; Uddin S; Mahmud D; Damacela I; Lavelle D; Ahmed M; van Besien K; Wickrema A
Biochem Biophys Res Commun; 2002 Oct; 297(4):760-4. PubMed ID: 12359217
[TBL] [Abstract][Full Text] [Related]
7. Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3.
Zhou Y; Uddin S; Zimmerman T; Kang JA; Ulaszek J; Wickrema A
Leuk Lymphoma; 2008 Oct; 49(10):1945-53. PubMed ID: 18728964
[TBL] [Abstract][Full Text] [Related]
8. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
9. Akt regulates skeletal development through GSK3, mTOR, and FoxOs.
Rokutanda S; Fujita T; Kanatani N; Yoshida CA; Komori H; Liu W; Mizuno A; Komori T
Dev Biol; 2009 Apr; 328(1):78-93. PubMed ID: 19389373
[TBL] [Abstract][Full Text] [Related]
10. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
11. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
Walter PL; Kampkötter A; Eckers A; Barthel A; Schmoll D; Sies H; Klotz LO
Arch Biochem Biophys; 2006 Oct; 454(2):107-13. PubMed ID: 16973122
[TBL] [Abstract][Full Text] [Related]
12. Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress.
Uranga RM; Katz S; Salvador GA
J Biol Chem; 2013 Jul; 288(27):19773-84. PubMed ID: 23687303
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
14. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
Sykes SM; Lane SW; Bullinger L; Kalaitzidis D; Yusuf R; Saez B; Ferraro F; Mercier F; Singh H; Brumme KM; Acharya SS; Scholl C; Tothova Z; Attar EC; Fröhling S; DePinho RA; Armstrong SA; Gilliland DG; Scadden DT
Cell; 2011 Sep; 146(5):697-708. PubMed ID: 21884932
[TBL] [Abstract][Full Text] [Related]
15. A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes.
Hill R; Kalathur RK; Callejas S; Colaço L; Brandão R; Serelde B; Cebriá A; Blanco-Aparicio C; Pastor J; Futschik M; Dopazo A; Link W
Breast Cancer Res; 2014 Dec; 16(6):482. PubMed ID: 25488803
[TBL] [Abstract][Full Text] [Related]
16. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta.
Escribano C; Delgado-Martín C; Rodríguez-Fernández JL
J Immunol; 2009 Nov; 183(10):6282-95. PubMed ID: 19841191
[TBL] [Abstract][Full Text] [Related]
17. Akt, FoxO and regulation of apoptosis.
Zhang X; Tang N; Hadden TJ; Rishi AK
Biochim Biophys Acta; 2011 Nov; 1813(11):1978-86. PubMed ID: 21440011
[TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanins affect myeloma cell fate via Akt signaling and FoxO activation.
Lishner M; Zismanov V; Tohami T; Tartakover-Matalon S; Elis A; Drucker L
Cell Signal; 2008 Dec; 20(12):2309-16. PubMed ID: 18804164
[TBL] [Abstract][Full Text] [Related]
20. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
